top of page

Efficacy of Psilocybin in OCD: a Double-Blind, Placebo-Controlled Study.

About the study

NCT Trial Number

NCT03356483

The drug being studied

Psilocybin

noun_Drug_2240951.png
noun_Institution_118530.png

Sponsored by

Yale University|Heffter Research Institute

noun_date_3237048.png

Trial Start Date

Nov-18

noun_capsule_138144.png

About the participants

Age seeking

21 Years to 55 Years

gender

All

noun_Mental Health_2683241.png

Primary condition of volunteers accepted

OCD

noun_square_138133.png

Accepts healthy volunteers?

No

This study aims to investigate the effects of oral psilocybin on the symptoms associated with OCD and provide the first evidence of the brain mechanisms undelying the treatment effect of psilocybin on OCD.

Eyes Graffiti

Locations

United States, Connecticut
Connecticut Mental Health Center
New Haven, Connecticut, United States, 06519

Contact: Ben Kelmendi, MD
203-974-7752
ben.kelmendi@yale.edu

​

​

​

​

Get in contact

Find a study site convenient for you below, then email yourself the contact details and next steps

bottom of page